Atlas Trials

Sorafenib + mFOLFOX for Hepatocellular Carcinoma

Clinical trial NCT01775501 · COMPLETED

Trial details

NCT number
NCT01775501
Sponsor
Massachusetts General Hospital
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
Hepatocellular Cancer
Start date
2013-01-01
Primary completion
2018-07-01
Enrollment
40

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.